Other

Debt Instrument, Unamortized Discount (Premium), Net

Thermo Fisher Scientific Debt Instrument, Unamortized Discount (Premium), Net decreased by 3.2% to $91.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.2%, from $96.00M to $91.00M. Over 5 years (FY 2020 to FY 2025), Debt Instrument, Unamortized Discount (Premium), Net shows relatively stable performance with a -1.6% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 1, 2026

How to read this metric

A large discount or premium indicates the company issued debt at rates significantly different from prevailing market rates at the time.

Detailed definition

This represents the net adjustment to the face value of debt resulting from the difference between the coupon rate and t...

Peer comparison

Common across all firms with significant bond market activity.

Metric ID: other_debt_instrument_unamortized_discount_premium_net

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$91.00M$107.00M$117.00M$112.00M$107.00M$101.00M$112.00M$112.00M$112.00M$108.00M$113.00M$108.00M$104.00M$104.00M$95.00M$96.00M$98.00M$95.00M$94.00M$91.00M
QoQ Change+17.6%+9.3%-4.3%-4.5%-5.6%+10.9%+0.0%+0.0%-3.6%+4.6%-4.4%-3.7%+0.0%-8.7%+1.1%+2.1%-3.1%-1.1%-3.2%
YoY Change+17.6%-5.6%-4.3%+0.0%+4.7%+6.9%+0.9%-3.6%-7.1%-3.7%-15.9%-11.1%-5.8%-8.7%-1.1%-5.2%
Range$91.00M$117.00M
CAGR+0.0%
Avg YoY Growth-2.6%
Median YoY Growth-4.0%
Current Streak3 quarters decline

Frequently Asked Questions

What is Thermo Fisher Scientific's debt instrument, unamortized discount (premium), net?
Thermo Fisher Scientific (TMO) reported debt instrument, unamortized discount (premium), net of $91.00M in Q1 2026.
How has Thermo Fisher Scientific's debt instrument, unamortized discount (premium), net changed year-over-year?
Thermo Fisher Scientific's debt instrument, unamortized discount (premium), net decreased by 5.2% year-over-year, from $96.00M to $91.00M.
What is the long-term trend for Thermo Fisher Scientific's debt instrument, unamortized discount (premium), net?
Over 5 years (2020 to 2025), Thermo Fisher Scientific's debt instrument, unamortized discount (premium), net has grown at a -1.6% compound annual growth rate (CAGR), from $102.00M to $94.00M.
What does debt instrument, unamortized discount (premium), net mean?
The net accounting adjustment to debt value based on interest rate differences at the time of issuance.